Cyxone
Cyxone AB is a clinical biotech company with a portfolio of immunomodulating drugs for the treatment of autoimmune diseases such as multiple sclerosis (MS) and rheumatoid arthritis (RA). Cyxone’s technologies have the potential to address an unmet need to develop new effective and safe medicines that can improve the quality of life for patients affected by autoimmune diseases. The company’s development portfolio comprises rabeximod in a clinical phase II program for RA and T20K that has successfully completed phase I infusion study for MS.
7-day free trial · no credit card
Verified contacts
5
available on Kipplo
LinkedIn employees
13
1 to 10 range
Open roles
—
no listings
Distinct roles
5
indexed titles
Tech stack
0
tools in use
Monthly traffic
7
organic / mo
Sign up free to see all 5 verified contacts at Cyxone
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
5 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Cyxone
5 distinct titles indexed · top 5 shown.
- 1chairman
- 1controller
- 1group ceo
- 1head of clinical operations
- 1office manager ceo assistant
Sign up to unlock all 5 contacts at Cyxone
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 5 verified contacts at Cyxone
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.